Dec 10, 2020

Chemists re-engineer a psychedelic to treat depression and addiction in rodents

Posted by in categories: biotech/medical, chemistry, neuroscience

“Researchers report today that they’ve created a nontoxic and nonhallucinogenic chemical cousin of ibogaine that combats depression and addictive behaviors in rodents. The work provides new hope that chemists may one day be able to create medicines for people that offer the purported therapeutic benefits of ibogaine and other psychoactive compounds without their side effects.”

Analog of ibogaine could hold hope for humans.

Leave a reply